- ￥4550
- Elabscience
- 武汉
- PKSH031972
- 2025年07月15日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
- 保质期：
12个月
- 英文名：
Recombinant Human IL-10/Interleukin-10 Protein
- 供应商：
武汉益普生物科技有限公司
- 规格：
100μg
| 产品名称 | Recombinant Human IL-10/Interleukin-10 Protein |
| 产品货号 | PKSH031972 |
| 种属 | Human |
| 别称 | Interleukin;RP11-262N;CSIF;GVHDS;IL-10;IL10A;TGIF;IL10;Cytokine synthesis inhibitory factor;Interleukin-10;MGC126450;MGC126451;RP11-262N9.1 |
| 简称 | IL-10;Interleukin-10 |
| UniProt | P22301 |
| 应用性 | Cell culture |
| 研究领域 | Cancer;immunology |
| 运输条件 | This product is provided as lyophilized powder which is shipped with ice packs. |
| 保存及保质期 | Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验, cryopreserving, and thawing human PBMCs; and finally, detecting vaccinia-specific IL-10 and IFNγ secreting lymphocytes, as well as CD8+ IFNγ T cells following in vitro stimulation of PBMCs with vaccinia virus. The methods presented below, although optimized
Methods for Producing Recombinant Human Cellular Retinaldehyde-Binding Protein
The cellular retinaldehyde-binding protein (CRALBP) is expressed at high levels in vertebrate visual trssue, where it may serve to modulate the interaction of 11-cis -retinol with visual-cycle enzymes in the retinal pigment epithelium (RPE
cytokines, including interleukins. Since reliable determination of cutaneous interleukin expression at the protein level is problematic (see Notes 1 –7 ), determination of mRNA expression came to the forefront of scientific interest. Such approaches
技术资料暂无技术资料 索取技术资料
